Skip to main
KYMR
KYMR logo

Kymera Therapeutics (KYMR) Market Capitalization Overview

Market Cap: $3.06B as of Jun 13, 2025

$3.06B
Past Month+$1.11B (56.43%)
As of Jun 13, 2025, Kymera Therapeutics (KYMR) has a market capitalization of $3.06B. Over the past 30 days, its market cap has increased by 25.17%, while in the last 12 months, it has increased by 17.37%.

Market capitalization represents the total value of Kymera Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Kymera Therapeutics (KYMR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Kymera Therapeutics (KYMR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Kymera Therapeutics (KYMR) Market Cap History

DateMarket CapChange
Jun 2, 2025$2.81B+25.17%
May 1, 2025$2.25B+36.91%
Apr 1, 2025$1.64B-16.36%
Mar 3, 2025$1.96B-21.40%
Feb 3, 2025$2.50B-5.87%
Jan 2, 2025$2.65B-14.35%

Kymera Therapeutics (KYMR) End of Year Market Cap History

DateMarket CapChange
2025$3.06B+17.37%
2024$2.61B+84.43%
2023$1.42B+3.16%
2022$1.37B-58.03%
2021$3.27B+18.36%
2020$2.76B

FAQs About Kymera Therapeutics (KYMR) Market Cap

As of Jun 13, 2025, the market capitalization of Kymera Therapeutics (KYMR) is $3.06B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Kymera Therapeutics’s market capitalization has increased by 56.43%, changing from $1.96B to $3.06B as of Jun 13, 2025.

In the last 3 months, Kymera Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Kymera Therapeutics’s market capitalization increased from $1.42B in January to $2.61B in December, reflecting a 84.43% change.

In the past five years, Kymera Therapeutics (KYMR) has had a compound annual growth rate (CAGR) of -1.12% in market capitalization. This means its market cap has shrunk at an average rate of -1.12% per year.

Kymera Therapeutics (KYMR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.